KEDRION S.P.A.

It is used for the treatment and prevention (prophylaxis) of bleeding in patients with hemophilia B (a factor IX deficiency present from birth) and for the treatment of acquired factor IX deficiency.

Dosage form: solution for infusion, powder and solvent for preparation

ATC: B02BD04

It is used to restore and maintain circulating blood volume in patients who have lost blood or body fluids and for whom the use of a plasma substitute is indicated.

Dosage form: solution for infusion

ATC: B05AA01

It is used to prevent the formation of blood clots (deep vein thrombosis and thromboembolism) in patients with an antithrombin deficiency, whether congenital or acquired. It may be used in clinical risk situations, such as during surgery or childbirth, often in association with heparin.

Dosage form: solution for infusion, powder and solvent for preparation

ATC: B01AB02

It is used for the prevention of deep vein thrombosis and thromboembolism in patients with an antithrombin deficiency (congenital or acquired), especially in high-risk situations such as surgical procedures or during childbirth. It may be used in association with heparin.

Dosage form: solution for infusion, powder and solvent for preparation

ATC: B01AB02

It is used to treat and prevent bleeding in patients with a congenital factor X deficiency, helping the blood to clot normally.

Dosage form: solution for injection, powder and solvent

ATC: B02BD13

It is used for the treatment and prevention of bleeding in people with hemophilia A (a hereditary deficiency of factor VIII) or in patients with factor VIII deficiency caused by other diseases. It is also used for those who have developed antibodies (inhibitors) against factor VIII.

Dosage form: solution for infusion, powder and solvent for preparation

ATC: B02BD02

It is used for the treatment of hemophilia A (mild and moderate) and von Willebrand disease (type 1), conditions characterized by altered factor VIII activity. It is also indicated for the preparation of patients with these conditions prior to surgical procedures.

Dosage form: solution for injection

ATC: H01BA02

It is used to treat bleeding in patients with hemophilia A (a hereditary deficiency of factor VIII), in patients with factor VIII deficiency caused by other diseases, in people with von Willebrand disease, and in hemophilic patients who have developed antibodies against factor VIII (inhibitors).

Dosage form: solution for injection, powder and solvent

ATC: B02BD02

It is used to restore and maintain circulating blood volume in patients who have lost blood or body fluids due to shock, burns, hypoproteinemic syndromes, starvation edema, cirrhosis, and other indications for plasma therapy.

Dosage form: solution for infusion

ATC: B05AA02

It is used for the treatment of adults, children, and adolescents who do not have enough antibodies (replacement therapy for primary or secondary immunodeficiencies) or to treat certain inflammatory diseases such as Primary Immune Thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, CIDP, and Multifocal Motor Neuropathy.

Dosage form: solution for infusion

ATC: J06BA02

It is used to prevent hepatitis B recurrence after a virus-induced liver transplant and to provide rapid protection against hepatitis B in cases of accidental exposure, in patients undergoing hemodialysis, in infants of virus-carrying mothers, or in those who have not responded to vaccination.

Dosage form: solution for injection

ATC: J06BB04

It is used to prevent immunization against the Rhesus D factor in Rh(D)-negative women. Specifically, it is used during pregnancy (both as scheduled prophylaxis and in case of complications), after the birth of an Rh(D)-positive child, and in the event of accidental transfusions of incompatible blood.

Dosage form: solution for injection, powder and solvent

ATC: J06BB01

IXED is used for the treatment and prevention (prophylaxis) of bleeding in patients with hemophilia B (a deficiency of factor IX present from birth) and for the treatment of acquired factor IX deficiency.

Dosage form: solution for infusion, powder and solvent for preparation

ATC: B02BD04

It is used for the treatment and prevention of bleeding in case of acquired deficiency of coagulation factors (e.g., caused by vitamin K antagonists) or in case of congenital deficiency of certain coagulation factors when the specific product is not available.

Dosage form: solution for infusion, powder and solvent for preparation

ATC: B02BD01

It is used to prevent hepatitis B recurrence after a virus-induced liver transplant and to provide rapid protection against hepatitis B in case of accidental exposure (in unvaccinated individuals), in patients undergoing hemodialysis, in infants of virus-carrying mothers, or in those who have not responded to vaccination.

Dosage form: solution for injection

ATC: J06BB04

It is used to restore antibody levels to normal in the blood of adult patients with primary immunodeficiencies. It is also indicated for the treatment of certain blood cancers (such as chronic lymphocytic leukemia and multiple myeloma) that cause low antibody levels and recurrent bacterial infections, or for those who have undergone a hematopoietic stem cell transplant.

Dosage form: solution for infusion

ATC: J06BA01

It is used to prevent hepatitis B recurrence after a liver transplant (in combination with antiviral therapy) and to provide rapid protection against the hepatitis B virus in case of accidental exposure, in patients undergoing hemodialysis, in infants of mothers who are carriers of the virus, or in those who have not responded to vaccination.

Dosage form: solution for infusion, powder and solvent for preparation

ATC: J06BB04

KLOTT is used for the treatment and prevention of bleeding in patients with hemophilia A (an inherited deficiency of factor VIII) or in patients presenting with a deficiency of this factor due to other diseases. It is also indicated for hemophilic patients who have developed antibodies against factor VIII (inhibitors).

Dosage form: solution for infusion, powder and solvent for preparation

ATC: B02BD02

It is used to restore normal antibody levels in the blood of adults with primary immunodeficiencies, to treat blood cancers that cause low antibody levels and recurrent bacterial infections, in patients with chronic lymphocytic leukemia or multiple myeloma, and in patients who are undergoing or have undergone hematopoietic stem cell transplantation.

Dosage form: solution for infusion

ATC: J06BA01

It is used to treat coagulation factor deficiencies (such as in consumption coagulopathies, severe hepatic impairment, or after massive transfusions), as emergency replacement therapy when specific concentrates are unavailable, to resolve fibrinolytic activity or the effect of certain oral anticoagulants, and for the management of Thrombotic Thrombocytopenic Purpura (TTP).

Dosage form: solution for infusion

ATC: B05AA02

It is used to treat coagulation factor deficiencies (such as in consumption coagulopathies, severe hepatic impairment, or after massive transfusions), as emergency replacement therapy when specific concentrates are unavailable, to resolve fibrinolytic activity or the effect of certain oral anticoagulants, and for the management of Thrombotic Thrombocytopenic Purpura (TTP).

Dosage form: solution for infusion

ATC: B05AA02

It is used to prevent tetanus after possible exposure through wounds, especially if not adequately vaccinated, if the immune status is unknown, or if there is an antibody deficiency. It can also be used for the treatment of tetanus that has already manifested, always in conjunction with vaccination.

Dosage form: solution for injection

ATC: J06BB02

It is used to restore and maintain circulating blood volume in patients who have lost blood or body fluids and for whom the use of a plasma substitute is indicated.

Dosage form: solution for infusion

ATC: B05AA01

It is used to prevent hepatitis B recurrence after a liver transplant and to provide rapid protection against the virus in case of accidental exposure (in unvaccinated individuals), in patients undergoing hemodialysis, in infants with a mother carrying the virus, or in those who have not responded to vaccination.

Dosage form: solution for injection

ATC: J06BB04

It is used for the treatment and prevention of bleeding in the event of an acquired deficiency of coagulation factors (for example, caused by vitamin K antagonists or their overdose) or in the event of a congenital deficiency of certain coagulation factors when the specific product is not available.

Dosage form: solution for infusion, powder and solvent for preparation

ATC: B02BD

It is used to prevent hepatitis B recurrence after liver transplantation (in combination with antiviral therapy) and to provide rapid protection against the hepatitis B virus in cases of accidental exposure, in patients undergoing hemodialysis, in infants of carrier mothers, or in those who have not responded to vaccination.

Dosage form: solution for infusion

ATC: J06BB04

This medicine is used to prevent hepatitis B recurrence after a liver transplant (in combination with antiviral therapy) and to provide rapid protection against the hepatitis B virus in cases of accidental exposure, in patients undergoing hemodialysis, in infants of mothers who are carriers of the virus, or in those who have not responded to vaccination.

Dosage form: solution for infusion, powder and solvent for preparation

ATC: J06BB04

This medicine is used for the treatment of adults, children, and adolescents in two main cases: as replacement therapy for those with insufficient antibody production (whether due to congenital or acquired causes) and for immunomodulation in certain inflammatory diseases, such as Guillain-Barré syndrome, Kawasaki disease, Immune Thrombocytopenia, CIDP, and Multifocal Motor Neuropathy.

Dosage form: solution for infusion

ATC: J06BA02